Details for Patent: 9,018,243

Summary for Patent: 9,018,243

Title:	Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
Abstract:	Solid forms comprising (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions comprising the solid forms, methods of making the solid forms and methods of their use are disclosed. The methods include methods of treating and/or preventing disorders ameliorated by the reduction of levels of TNF-α or the inhibition of PDE4.
Inventor(s):	George W. Muller, Peter H. Schafer, Hon-Wah Man, Chuansheng Ge, Jean Xu
Assignee:	Amgen Inc
Application Number:	US14/102,407
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,018,243
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 9,018,243

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 9,018,243

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2962690		300994	Netherlands
European Patent Office	2962690		LUC00125	Luxembourg
European Patent Office	2962690		122019000070	Germany
European Patent Office	2962690		CA 2019 00033	Denmark
European Patent Office	2962690		2019C/008	Belgium